SEC Form 4 · accession 0001219036-15-000008
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerry S Lanchbury
Officer — Chief Scientific Officer
Period of report
Oct 28, 2015
Accepted (ET)
Oct 28, 2015 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 28, 2015 | M | 50,962 | $22.93 | A | 121,699 | D | |
| Common Stock | Oct 28, 2015 | S | 50,962 | $41.86 | D | 70,737 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $22.93 | Oct 28, 2015 | M | 50,962 | D | — | Sep 10, 2018 | Common Stock | 50,962 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F2The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.